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Title Page 
 
Study Title 
A phase II Randomized Controlled Clinical Trial to assess the effectiveness of Alveolar 
Recruitment Maneuver (RM) in Improvement of Lung Compliance during Laparoscopic 
Surgery in Children 
Indication studied 
The investigators will test the hypothesis that RM during Abdominal Laparoscopic Surgery in 
Children aged 1-14 years improves lung compliance and gas exchange. The investigators will 
apply RM as a Sustained Inflation (at a pressure level of 30 cm H2O for 30 seconds) in pediatric 
patients under Pressure Controlled Ventilation (PCV) after deflation of pneumoperitoneum.  
Brief description 
This will be an Interventional, Prevention, Parallel Assignment, Double-blind (patient, care-
giver, outcomes Assessor), Randomized, Safety / Efficacy Study. We will use two parallel 
groups of children aged 1-14 years who are scheduled for elective Abdominal Laparoscopy 
Trial Site, Patient Enrollment, Start and Completion Date 
Trial Site: General Hospital of Thessaloniki “Papageorgiou” 
Enrollment: 30 patients 
Study Start day: XXXXXXX 
Primary Completion date: XXXXXXX  
Study Completion date: XXXXXXX 
Protocol Identification 
ClinicalTrials.gov Identifier: XXXXXXX  
Study ID Number: XXXXXXX 
Principal Investigator 
XXXXXXX  
Sponsor 
General Hospital of Thessaloniki “Papageorgiou”, Ring Road, Pavlos Melas, Thessaloniki, 
56403 
Ethics 
The Institutional Review Board will review and approve the study.  
This study will be performed in compliance with good clinical practice (GCP): International 
Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals 
for Human Use - ICH Harmonised Tripartite Guideline - Structure and Content of Clinical Study 
Reports  
Patient Information and Consent 
Written informed consent will be obtained from minors’ parents or patients’ legally 
acceptable representatives. Patients will be informed about the trial to the extent compatible 
with their understanding and, if capable, patients should sign and personally date informed 
consent form. 
Protocol version 
Version: 5.6 (21/9/2017) 
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ASA American Society of Anesthesiologists Physical Status classification system 
BMI Body Mass Index 
CO2 Carbon dioxide 
IAP Intra-abdominal pressure 
IBW Ideal Body Weight 
MinV Minute Ventilation 
MV Mechanical Ventilation 
PACU Post-Anesthesia Care Unit 
PCO2 Partial Pressure of Carbon Dioxide 
PCV Pressure-controlled Ventilation 
PEEP Positive end-expiratory pressure 
PetCO2 End-tidal carbon dioxide concentration 
pH Power of Hydrogen 
PI Principal investigator 
PIP Peak Inspiratory Pressure 
PO2 Partial Pressure of Oxygen 
PO2 / FiO2 Arterial Oxygen Partial Pressure to Fraction of Inspired Oxygen 
RM Recruitment Maneuver 
RR Respiratory Rate 
SI Sustained Inflation 
SpO2 Peripheral Oxygen Saturation 
Vt Expiratory Tidal Volume 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 02:36:04 EEST - 137.108.70.13
8 
 
Abstract 
 
Introduction 
Pneumoperitoneum and increase in Intra-abdominal Pressure in Children Laparoscopy 
reduces diaphragmatic excursion and shifts the diaphragm cranially, resulting in the reduction 
in Lung Compliance and Functional Residual Capacity and Ventilation – Perfusion (V/Q) 
mismatch leading, finally, to atelectasis, hypoxemia and hypercapnia. In a prospective 
randomized double-blind clinical trial, the investigators will test the hypothesis that alveolar 
Recruitment Maneuver (RM) during Laparoscopy in children aged 1-14 years improves Lung 
Compliance. The primary endpoint of the study will be the improvement in dynamic lung 
compliance (Comdyn) (dv/dp) while the improvement in gas exchange (increase in PO2, 
PO2/FiO2, and decrease in PCO2) will be the secondary endpoint of the study. 
 
Materials and Methods 
Children undergoing Abdominal Laparoscopy will prospectively be assigned to one of two 
groups. During the operation, patients In both groups, will be ventilated with Pressure-
Controlled Ventilation (PCV) with Positive End-Expiratory Pressure (PEEP) 5 cm H2O and 
titration to achieve Tidal Volume (Vt) 6-7 ml/kg and End-tidal CO2 (EtCO2) 35-40 mmHg.  In the 
RM group, 3 minutes after deflation of pneumoperitoneum, the investigators will apply RM 
as a Sustained Inflation with CPAP 30 cm H2O for 30 seconds, by setting Manual / Spontaneous 
Ventilation Mode and the Adjustable Pressure Limitation (APL) Valve to 30 cm H2O. In both 
groups, lung compliance will be measured (dynamic compliance) as dv/dp (ml/cm H2O). 
Measurements (including hemodynamics and blood gas) will be assessed after a stabilization 
period of Mechanical Ventilation (MV), as baseline before surgical incision, during the 
pneumoperitoneum, after deflation, after RM and in Post-Anesthesia Care Unit (PACU). A 
power analysis will be conducted in order to compare Dynamic Lung Compliance (dv/dp) 
between the two study groups. The improvement in Dynamic Compliance will be the Primary 
Endpoint of the study. Children will be assigned in a 1:1 ratio to one of the two groups using 
software-generated blocks. 
 
Results and Discussion 
Data will be presented as mean value (+/- SD) and  p < 0.05 will be considered significant. The 
investigators will use Mixed Analysis of Variance to make comparisons between and within 
groups. At time points before RM is performed, there should be no significant differences in 
Lung Compliance between the two groups (p > 0.05). The investigators will use two-sample t-
test as supplementary analysis in order to compare the two groups at each time point, while 
chi-square test for categorical variables and two-sample t-test for continuous variables for 
patient and procedural characteristics differences between the two groups will be used. In the 
RM group, according to similar studies, we expect to detect a significant increase in lung 
Compliance after RM in comparison to control group where RM will not be applied. In the RM 
group, the investigators estimate that Dynamic Lung Compliance will be significantly increased 
compared to baseline compliance too. There should be no significant differences in 
demographics between the two groups.  The investigators expect that there will be no 
statistical or/and clinical significant differences in patients’ hemodynamics and blood gas 
measurements. 
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Introduction 
 
Recruitment Maneuver – Definition 
Alveolar recruitment maneuver (RM) is a technique using sustained airway pressure increase 
aiming at recruiting collapse alveoli, increasing lung area available for gas exchange and 
consequently improving arterial oxygenation. 
 
General Anesthesia, Atelectasis and Recruitment Maneuver 
Mechanical ventilation (MV), during General Anesthesia (GA), should not be considered as a 
simple and neutral intervention, without potential serious consequences in patient’s 
homeostasis. In fact, Positive Pressure MV is increasingly recognized as a potentially harmful 
intervention that can cause lung damage (Ventilator-Induced Lung Injury – VILI) and 
respiratory muscle injury (Ventilator-Induced Diaphragm Dysfunction - VIDD). 
 
Between the several mechanisms that have been postulated to describe the development of 
VILI, Atelectasis plays an important role, as in the presence of atelectasis, MV may harm the 
alveolar units by repetitive collapse and reopening, a condition that is called  atelectrauma1. 
 
Atelectasis develops in as much as 90% of patients undergoing general anesthesia2 and can be 
present to different degrees after surgery, maybe for days. It occurs in the dependent parts 
of the lungs and the development of atelectasis is associated with several pathophysiologic 
effects, including decreased lung compliance, impairment of oxygenation and increased 
pulmonary vascular resistance3. Atelectasis is a major cause of intra- and post- operative 
hypoxemia while it also predisposes to postoperative lung infections.  
 
The consequences of atelectasis persist into the postoperative period and can influence 
patient recovery3; over the last years there is growing evidence that an intraoperative lung-
protective mechanical ventilation strategy, using low Tidal Volumes (Vts), with or without high 
levels of Positive End-Expiratory Pressure (PEEP) and Recruitment Maneuvers (RMs), prevents 
Post-operative Pulmonary Complications (PPCs)3,4.  
 
Laparoscopic Surgery in Adults and Children 
In the recent years, advances in laparoscopic technique and refinement in the equipment have 
led to a significant increase in the use of Laparoscopy in Children, offering its benefits to young 
patients. In comparison to conventional open technique, Laparoscopy is related with reduced 
surgical trauma, less postoperative pain, reduced perioperative morbidity, earlier 
postoperative mobilization, shorter hospital stays and better cosmetic results5.  
 
Nevertheless, from the anesthetic point of view, Laparoscopic Surgery exposes the patient to 
additional physiological modifications and thus potential risks. Laparoscopic Surgery involves 
the intraperitoneal insufflation of carbon dioxide (CO2) to permit adequate visualization and 
manipulation of the abdominal viscera. The pneumoperitoneum, except the CO2 absorption, 
involves an increase in the Intraabdominal Pressure (IAP), which, among other, can have 
significant cardiovascular, respiratory and neurological effects. A thorough understanding of 
the pathophysiological changes mentioned above is crucial  for optimal anesthetic care6–8. 
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CO2 Absorption effects 
During intraperitoneal insufflation, CO2 diffuses to the body and its diffusion leads to 
increased PaCO2 (tension of carbon dioxide in arterial blood) values in the intra- and post- 
operative period9. Hypercapnia constitutes a strong stimulus for Minute Ventilation (MinV) to 
increase, by as much as 60%, to normalize the End-tidal CO2 (EtCO2) while it activates the 
sympathetic nervous system leading to an increase in blood pressure, heart rate, myocardial 
contractility, and arrhythmias. It also sensitizes the myocardium to catecholamines, 
particularly when volatile anesthetic agents are used10. 
 
Hemodynamics during Laparoscopy 
Main hemodynamic changes include alterations in arterial blood pressure (i.e., hypotension 
and hypertension) and arrhythmias. The extent of the cardiovascular changes associated with 
creation of pneumoperitoneum depends on the level of IAP, volume of CO2 absorbed, 
patient’s intravascular volume, ventilatory technique, surgical conditions and anesthetic 
agents used. However, the most important determinants of cardiovascular function during 
laparoscopy are the IAP and patient position8. 
 
Pulmonary Function during Laparoscopy 
Changes in pulmonary function during laparoscopy include reduction in lung volumes, 
increase in peak airway pressures, and decrease in pulmonary compliance, secondary to 
increased IAP and patient positioning11. 
 
Creation of pneumoperitoneum at an IAP of 15 mm Hg reduces respiratory system compliance 
and increases peak inspiratory and mean airway pressures. Elevated IAP reduces 
diaphragmatic excursion and shifts the diaphragm cranially, resulting in early closure of 
smaller airways leading to intraoperative atelectasis with a decrease in functional residual 
capacity. On one hand, upward displacement of the diaphragm leads to preferential 
ventilation of nondependent parts of the lung, which results in ventilation-perfusion (V/Q) 
mismatch with a higher degree of intrapulmonary shunting, whereas on the other, it leads to 
endobronchial intubation. These pulmonary pathophysiological changes lead to hypercapnia 
and hypoxemia, in case of non-effective ventilation, and to pulmonary vasoconstriction8,10 
 
Blood gas changes and respiratory mechanics are affected by the duration of 
pneumoperitoneum and patient positioning. The deterioration in respiratory function is 
reduced when the patient is in the reverse Trendelenburg position and worse when the 
patient is in the Trendelenburg position11. 
 
Ventilation strategy during Laparoscopy 
The above physiological modifications during Laparoscopy, have been already extensively 
studied both for adults12 and for children7,13–15.  
 
Regarding adult patients, the reasonable idea of using during Laparoscopy a Ventilatory 
Strategy closer to Protective Ventilation Strategies (with low Vt, PEEP and RM) has been 
already studied with positive results16–19. 
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On the contrary, while RM has been extensively studied in the context of Pediatric Intensive 
Care Units (PICUs) with positive results as well20–25,  there is a paucity in literature about 
performing RM during Laparoscopic Surgery in Children. 
 
 
Study Objectives 
In this study, overall, we will test the hypothesis that the application of RM after deflation of 
pneumoperitoneum during Abdominal Laparoscopy in Children improves Lung Dynamic 
Compliance (Comdyn) and Perioperative Oxygenation. In this study, we aim to suggest that the 
Recruitment Maneuver could reverse Lung Atelectasis which is a major cause for respiratory 
complications intra- and post-operatively.  
 
 
Investigational Plan 
 
Study population and Control Group 
This will be a Prospective, Randomized, Double-blind, Controlled Clinical Trial. After approval 
of the Institutional Ethics Committee (Papageorgiou General Hospital of Thessaloniki, 
Scientific and Ethic Committee), this trial will be conducted at Papageorgiou General Hospital, 
starting from XXXX XXXX. After having obtained written informed consent for the participation 
in the study (see below: Ethics), 30 children (the number originates from the power analysis – 
see below) with American Society of Anesthesiology Classification scores (ASA) 1 – 2 will be 
scheduled for Abdominal Laparoscopic Surgery. The Control Group will be managed with a 
more conventional anesthetic practice (no recruitment, moderate levels of PEEP). This will be 
a non-treatment concurrent control trial. 
 
Inclusion Criteria 
Children aged between 1-14 years who are scheduled for elective Abdominal Laparoscopy will 
be eligible for this study.  
 
Exclusion Criteria 
Exclusion criteria will be parental or patient refusal, Body Mass Index (BMI) > 40, history of 
prematurity (birth at post-conceptual age < 37 weeks) or history of congenital lung disorder, 
clinically recognized airway disease, obstructive or restrictive lung disease, pulmonary 
hypertension, congenital or acquired heart disease, history of intrathoracic instrumentation, 
history of severe brain injury and intracranial hypertension.  
In addition, all patients who, from the induction of anesthesia until the deflation of 
pneumoperitoneum, will present any cardiovascular or respiratory major complication (i.e. 
massive blood loss, arrhythmia, laryngospasm, bronchospasm) will be excluded from the 
study. In addition, patients will be excluded in case laparoscopy will be converted  to open 
operation due to surgical reasons. 
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Removal of Patients from Therapy 
Hemodynamic instability during the RM will be the main cause for removing patients from 
therapy, defined as persistent Hypotension (SBP <70 mm Hg in those 1–4 years, <80 mm Hg 
in those 5–12 years, and <90mm Hg in those >12 years). Hypoxemia (oxygen saturation <92%), 
bradycardia (heart rate <80 bpm in those <2 years, <60 bpm in those > 2 years) or arrhythmias 
will also impose the removal of RM and application of therapeutic measurements in case the 
symptoms insist. 
 
 
Randomization 
In order to perform Randomization, the investigators  will use web-software-generated blocks 
(available at: http://www.randomization.com/). Patients will be randomized to one of the two 
Ventilation Management Groups (RM or Control group) with 15 patients per group. Each 
patient assigned to participate in the study will have a sequentially numbered (from 1 to 30) 
sealed envelope containing Randomization Code (A or B). The Principal Investigator will be the 
only person who will be aware of the correspondence between Codes and study Groups.  The 
envelopes will be concealed until deflation of pneumoperitoneum, just prior to application of 
RM (or not). All operations will be performed by the same team of surgeons and by the same 
anesthesiologists (PI and Second Investigator). In Appendix 1, there is an example of 
performed permuted blocks randomization with 30 patients, created by this web-software. 
 
 
Interventions & Treatments 
 
Anesthetic Management (prior to manipulation) 
Patients of each group will have the same standardized anesthetic management.  
 
Preoperative assessment 
Preoperative assessment will be conducted to all eligible patients by the Principal Investigator 
(PI) according to local routine practice, few days or the day before the operation. During the 
preoperative evaluation, PI will obtain written informed consent (see below: Ethics). 
 
Premedication 
Patients will be premedicated 30-60 minutes before the procedure with midazolam 0,5 mg/kg 
po (maximum dose: 15mg).  
 
Monitoring and Induction 
ASA Standard noninvasive monitors will be applied before the induction of anesthesia. 
Induction will take place with inhalational technique with sevoflurane. When patients will 
reach stage 3 of anesthesia, an intravenous catheter will be inserted. Tracheal intubation, with 
a cuffed Endotracheal Tube (ETT) appropriate for each patient’s size, will be performed after 
the iv administration of fentanyl 1 mcg/kg, lidocaine 1 mg/kg, rocuronium 0,6 mg/kg and 
adequate low doses of propofol, if necessary. The ETT cuff pressure will be measured with a 
Portex low pressure scale manometer and will be maintained at 20-25 cm H2O. After the 
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induction, an arterial catheter will be placed in the radial artery for invasive blood pressure 
monitoring and blood gas measurements. 
 
Maintenance of anesthesia 
Maintenance of anesthesia will be performed using sevoflurane (MAC: 1,2-1,4) and a mixture 
of oxygen and air (FiO2 0.4). Fentanyl and/or remifentanil will be used for intraoperative 
analgesia as appropriate.  
Ringer’s Lactate solution will be used for routine intraoperative fluid management. 
Maintenance doses of rocuronium will be guided by Monitoring of Neuromuscular Function 
of the Ulnar nerve with a Peripheral Nerve Stimulator, to maintain Post-Tetanic Count 1-2. 
Subsequent care will be at the discretion of the anesthetic team and will not be part of the 
study.  
 
Ventilation Strategy 
 
Baseline Ventilation Strategy 
Pulmonary ventilation in all patients will be supported with Dräger Primus Anesthesia 
workstation (SW 4.5n) Ventilator.  
Baseline ventilatory parameters include Pressure-Controlled Ventilation (PCV), Positive End-
Expiratory Pressure (PEEP) of 5 cm H2O, and Peak Inspiratory Pressure (PIP) of 10-15 cm H2O. 
These parameters will be titrated to achieve a Vt of 6-7 mL/kg Ideal Body Weight (IBW) and a 
Respiratory Rate (RR) of 12-20 breaths/min and then finally adjusted to achieve an End-tidal 
CO2 (EtCO2) of 35-40 mmHg and a target SPO2 of ≥ 97 %.  
Ventilatory parameters will be manually recorded from the Anesthesia workstation monitor 
screen.  
Ventilatory adjustments will be performed during each period, increasing PIP by 2 cm H2O 
until a VT of 6-7 mL/kg IBW or within 10% of baseline Vt will be obtained, with a maximum PIP 
of 25 cm H2O and EtCO2 of 35-40 mmHg. Respiratory rate will be increased by 2 breaths/min 
after adjusting Vt to maintain an EtCO2 of 35-40 mmHg. Operating room table angle will be 
measured with a Johnson Magnetic Angle Locator.  
 
 Recruitment Maneuver (Time and Method of RM) 
After deflation of pneumoperitoneum, patients in Control group will continue to be ventilated 
with the same ventilation settings while RM will be performed to patients in RM group. 
Since the locally available Anesthesia Workstation does not permit CPAP > 20 cm H2O26, RM 
will be performed by setting Manual / Spontaneous Ventilation Mode and by setting 
Adjustable Pressure Limitation (APL) Valve to 30 cm H2O for 30 seconds (Fresh Gas Flow: 5 
lt/min, FiO2 0,4), measured by operating room digital clock, while monitoring the patient for 
signs of adverse effects, such as hemodynamic instability.  
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 Ventilation Management Flowchart 
 
 
 
 
Anesthetic Management (post-manipulation) 
 
Ventilation Strategy (post-manipulation) 
The patients of the RM group, after the RM, will be ventilated with the Standardized 
Ventilation strategy described above. The patients of the Control group will be ventilated with 
the same strategy throughout the surgical procedure. 
 
Reversal of the residual blockade, Extubation and Post-Anesthesia Care 
At the end of the procedure, residual neuromuscular blockade will be reversed with adequate 
doses of suggamadex. Tracheal extubation will be performed and the patient will be 
transported to the Post-Anesthesia Care Unit (PACU) according to the local practice. Patients 
will be discharged according to standard PACU discharge criteria. 
 
 
Measurements 
 
Primary endpoint 
The improvement of Comdyn will be the primary endpoint of the study. Comdyn will be 
measured automatically by the Dräger Primus Anesthesia workstation (SW 4.5n). Comdyn is 
determined from Pplateau and Expiratory Tidal Volume and is equal to the measured Total 
Compliance [Vt / (Pplateau – PEEP)] minus the System and Hose Compliance determined in 
the Self-Test of the workstation.  Weight-corrected Comdyn  will be calculated by dividing 
Comdyn by the weight of patient in kilograms (Comdyn-wc = Comdyn /weight). Time points of 
measurements are defined below. 
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Secondary measurements 
Secondary Mechanical Ventilation measurements will be PIP, Expired Vt, RR, MV, EtCO2. 
Hemodynamic measurements will include Arterial Blood Pressure (Systolic, Diastolic, Mean), 
and Heart Rate. Blood gas data Measurements will be pH, PO2, PCO2, SPO2 and PO2/FiO2. 
 
Time points of measurements 
After a stabilization period of 1-2 minutes of Mechanical Ventilation (stabilization defined as 
a stable Vt for at least 4 consecutive breaths), the above parameters (except Blood gas 
measurements – see Appendix 6) will be measured at the following time points: 
 
T1 Baseline After tracheal intubation and ventilation stabilization, with 
the patient in the supine position and before surgical incision 
T2 Pneumoperitoneum After insufflating CO2 to the defined IAP 
T2c Correction After adjusting PIP to return Vt to 6-7 ml/kg IBW or within 10% 
of baseline 
T3 Trendelemburg After Trendelemburg positioning 
T3c Correction After Trendelemburg positioning and after adjusting PIP to 
return Vt to 6-7 ml/kg IBW or within 10% of baseline 
T4 Deflation After completing the laparoscopic procedure with the patient 
returned to the supine position with the abdomen deflated 
T4c Correction Post-deflation correction, after returning PIP to baseline 
T5 After RM / Before 
Reversal of 
Neuromuscular 
Blockade 
3 minutes after RM in the RM group and before the reversal 
of neuromuscular blockade and Extubation in both groups 
T6 Post-operative 30 min after the admission in PACU 
 
 
Follow up measurements 
There will be a postoperative follow up for all patients participating in our study, concerning, 
among other, signs and symptoms of respiratory failure. Respiratory failure practically means 
the need for invasive or non-invasive ventilation after extubation. In such case, we should 
define the pulmonary pathophysiology involved, i.e. pneumonia, atelectasis, pulmonary 
embolism, pneumothorax, acute lung injury (ALI), asthma, non-cardiogenic pulmonary edema 
and severe hypercapnia. The routine postoperative oxygen will be applied for 30 minutes 
postoperatively and will also be noted. 
 
End of Treatment 
The treatment (RM) will start 3 minutes after the Pneumoperitoneum deflation and will last 
for 30 seconds. 
 
End of Study 
The patients will be monitored throughout the operation and in the postoperative period too, 
in PACU and in Pediatric Clinic (see also the measurements section - primary endpoint, 
secondary measurements and follow up). Patients will be followed up during their hospital 
stay, the length of which will be recorded. Possible adverse events during the hospital stay 
will also be recorded.  
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Efficacy and Safety Issues 
 
The efficacy of the RM to improve Comdyn and gas exchange is the main issue of this study. 
The investigators regard that Comdyn will be statistically significantly improved in the RM group 
compared to Control group. In this study, we consider clinically significant a 20% increase in 
the weight corrected mean Comdyn in the RM group. 
 
This improvement in lung compliance maybe would not be clinically significant, as our study 
population consists of healthy children (children with ASA I-II classification). Nevertheless, the 
possibility of underlying comorbidities should always be taken into account and anesthesia in 
addition to these comorbidities could negatively influence cardiovascular and pulmonary 
function, and thus patients’ outcome. This is the reason that ventilation strategy adopted in 
this study has a protective-lung ventilation strategy orientation, with lower Vt and higher PEEP 
than usual in clinical practice the past years. 
 
The investigators regard that there would be statistical significant difference within RM group, 
as well. Comdyn is expected to be significantly improved in post-RM measurements in 
comparison to baseline Comdyn, for the patients of RM group. A 20% increase in Comdyn would 
be clinically significant too. 
 
Secondarily, the investigators regard that RM will improve post-RM intra- and post-operative 
PO2 and  ratio PO2/FiO2. For the population of this study (children ASA I-II), this improvement 
may also not have a clinically significant impact. 
 
Although recruitment procedures are generally well tolerated with few adverse effects, there 
are several potential complications that could occur28.  
 
Because of the transient increase in intrathoracic pressure and consequent reduction in 
venous return, cardiac output may be impaired, producing hypotension – a complication that 
appears to be more common in patients with poor chest wall compliance and limited 
oxygenation response from recruitment29. Generally, hypotension during the maneuver 
suggests relative volume depletion28. In this study, RM will be performed with a parallel beat-
to-beat hemodynamic monitoring (Invasive Arterial Blood Pressure Monitoring). Patients with 
severe hemodynamic instability (hypotension or arrhythmias) will be removed from the study, 
as already mentioned. In these patients, the removal of RM is expected to improve arterial 
blood pressure – in case hypotension persists, vasoconstrictors (ephedrine, norepinephrine) 
will be administered in adequate for each patient doses. 
 
A decrease in cerebral perfusion pressure has been noted as a RM complication, which may 
contraindicate this procedure in head injured patients30. In this study, patients with  history 
of severe brain injury and intracranial hypertension meet the exclusion criteria and will be 
excluded. 
 
Barotrauma, including pneumothorax and pneumomediastinum, has been also described but 
the exact risk remains unclear28. Nevertheless, when RM is performed with the duration and 
the pressure levels adopted in this study (Sustained Inflation with CPAP 30 mm H2O for 30 
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seconds) is thought to be a safe clinical maneuver without such major complications to 
children20–25 
 
 
Adverse Events 
In addition to RM complications (see above), any perioperative adverse event will be 
recorded, such as laryngospasm, bronchospasm, pneumothorax, subcutaneous emphysema, 
hypotension, bradycardia, desaturation (SPO2 < 92%) or hypercapnia (PaCO2 > 45 mmHg). 
 
 
Patient Records  
For each patient we will have 4 data files 
1. Demographic, intra- and post-operative patient data (Appendix 3) 
2. Mechanical Ventilation data (Appendix 4) 
3. Hemodynamic data (Appendix 5) 
4. Blood Gas data (Appendix 6) 
 
 
Blinding Procedure 
This will be a Double-blind clinical study. Patients will not be aware of ventilation strategy 
during the operation. The only un-blind person will be the Principal Investigator (PI). After the 
RM (or not), at T4 point time (see below), a Second Investigator (SI) will come into the 
operating room and will record measurements from monitor. The same person will also 
perform blood gas analyses on the specified time points and postoperative records in PACU. 
The measurements will be recorded in special files for each separate patient with patient id 
number and then will be entered in a SPSS data file (SPSS version 22) and will be analyzed. 
Analysis will be performed by the two investigators separately (the PI will be un-blind) and 
results should be matched.  
 
 
Statistical Methods 
 
Sample size determination 
Power Analysis will be conducted for determination of the Sample Size of this study, in order 
to estimate a Sample Size that is required so that the study would have adequate power to 
detect clinically meaningful differences between the two groups, especially concerning  Lung 
Compliance (which is the primary outcome of the study). 
For this analysis, we used G*Power Software27 (version 3.1.9.2), which is freely available at 
http://www.gpower.hhu.de/en.html from the Heinrich-Heine-Universität of Dusseldorf. 
Our Power Analysis is based on a published study in literature, from Manner et al15. Assuming 
that Clinically meaningful difference between the two groups is 20% of the mean value and 
SD of the observed Lung Compliance is 15% of the mean value15, therefore Size effect = 0.2 / 
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0.15 = 1.33, with two-sided testing, with alpha = 0.05 and power = 0.9 (therefore, b = 1 – 
power = 0.1). Under these assumptions, G*Power calculated that we will need minimum 13 
patients in each group (totally, 26 subjects) for this study to have adequate power.  
Assuming a 15% drop-out rate of the initial number of subjects enrolled to this trial, total 
number of 30 patients will have to be randomized 
Alternatively, using the adequate mathematic formula (see Appendix 2) and the results from 
the Manner et al15 study, we confirm a minimum Sample Size of 26 patients. 
 
Statistical Analysis 
Investigators will assess data for normality (using Kolmogorov Smirnoff and Shapiro Wilks 
test). Ventilatory and hemodynamic data and intraoperative and postoperative variables (all 
continuous variables) will be presented as mean values (+/- SD). Data will be compared 
between and within groups using Mixed Analysis of Variance (Mixed Anova - General Linear 
Model) if are normally distributed or with Kruskal Wallis test in case that we do not have 
normally distributed data. Bonferroni correction will be used for multiple comparisons 
correction. In order to check and supplement our Mixed Analysis of Variance we will also use 
two-sample t-test to compare the two groups at each time point (for ventilatory and 
hemodynamic variables). Patient and procedural characteristics will be compared between 
groups using independent-sample t-test for continuous variables and chi-square test for 
categorical variables. Two tailed P-values < 0.05 will be considered statistically significant. For 
data analysis, the investigators will use SPSS statistical software (version 22). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 02:36:04 EEST - 137.108.70.13
19 
 
Data Presentation Plan 
 
Flow chart 
Supposing the number of eligible children is k and the number of excluded children before 
randomization is e, with possible reasons for exclusion (e1, e2, e3), trial flow chart is shaped 
as below. 
Finally, 30 patients will be randomized in two groups.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
If the great majority of the patients will complete the study, we will use a Per Protocol analysis. 
If many of the randomized patients will not complete the study, we will use an Intention to 
Treat analysis of data (ITT). According to ITT analysis of data, we will use all the data of all the 
randomized patients regardless of whether they completed the trial or not. For the missing 
values we will use the Last Observation Carried Forward (LOCF) approach. 
Number of Eligible 
Children (k) 
Number of Patients 
Excluded (e) 
e1  exclusion reason1 
e2  exclusion reason2 
… 
 
15 pts in RM group 
30 pediatric patients 
randomized 
15 pts in Control  group 
x pts did not 
complete the study 
x1  reason 1 
x2  reason 2 
… 
y pts did not 
complete the study 
y1  reason 1 
y2  reason 2 
… 
q1 completed the study q2 completed the study 
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Patient demographics should be similar between the two groups (Table 1). If not, differences 
will be mentioned and this will be a major limitation of our study. 
Intraoperative characteristics (anesthesia duration, pneumoperitoneum duration, IAP, blood 
loss, administration of crystalloids and / or blood products and intraoperative use of 
vasoconstrictors should be similar between the two groups (Table 1). 
The length of hospital stay and the possible differences between the two groups should be 
mentioned (Table 1). The number of patients that will develop postoperative pulmonary 
complications (mainly pneumonia, diagnosed with clinical evaluation and chest radiogram) 
and possible differences between the two groups should also be recorded.  
Pneumothorax and pneumomediastinum would be serious complications, which could have a 
strong relationship with the RM manipulation, and should be also recorded (see adverse event 
section above) 
 
Table 1. Patient demographics presented as mean (SD) or n = number of patients. Intra- post- 
operative events presented as mean (SD) 
 
 RM group (n = 15) Control group (n =15) 
Patient Demographics 
Age (years) [mean (SD))   
ASA (n) [mean (SD))   
Weight (grams)    
Height (m)   
BMI (kg/m2)   
Sex (male / female)   
Intraoperative characteristics 
Duration of Anesthesia (min)   
Duration of Pneumoperitoneum (min)   
IAP (mmHg)   
Crystalloids (ml)   
Blood (units)   
Need for Vasoconstrictor drugs (n)   
Postoperative characteristics 
Length of Hospital stay (days)   
Pulmonary Complications (n)   
Pneumothorax (n)   
Pneumomediastinum (n)   
Pneumonia (n)   
Other (n)   
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Study committees 
 
Executive Committee (EC) 
The EC will consist of members of the academic leadership of the study and 1 member from 
the sponsor. The EC will ultimately be responsible for the conduct of the study including 
addressing any Data Monitoring Committee recommendations and overseeing publication of 
the results. 
 
Steering Committee 
A Steering Committee will be formed consisting of members who are lead investigators. The 
Steering Committee will advise and assist the EC with regard to the scientific and operational 
aspects of the study. 
 
Independent Data Monitoring Committee (DMC) 
This study will be conducted under the auspices of an independent Data Monitoring 
Committee (DMC), which will monitor the progress of the study and ensure that the safety of 
subjects enrolled in the study is not compromised. The DMC will have a chairperson and 
include at least 2 anesthesiologists, a pediatric surgeon as well as a statistician. This 
committee will review accumulating data on a regular basis and may request to review 
partially unblinded or unblinded accumulating data. The DMC will make recommendations to 
the Executive Committee and Sponsor regarding the continuing safety of subjects currently 
enrolled and yet to be enrolled in the trial. At all times during the course of the study, the 
DMC may request access to unblinded data if needed. 
 
 
Ethical Considerations 
 
This study will be conducted in compliance with the protocol, the ethical principles set forth 
in the Declaration of Helsinki, the ICH Guideline E6 for GCP and applicable regulatory 
requirement(s). Good clinical practice (GCP) is an international ethical and scientific quality 
standard for designing, conducting, recording, and reporting research studies that involve the 
participation of human subjects. Compliance with this standard provides public assurance that 
the rights, safety, and well-being of study subjects are protected, consistent with the 
principles that have their origin in the Declaration of Helsinki. 
 
Institutional Review Board / Independent Ethics Committee 
The protocol and any amendments, the Investigator’s Brochure, the subject informed consent 
and any information on compensation for study-related injuries or payment to subjects, will 
receive IRB / IEC approval prior to initiation of the study. During the study the investigator will  
send to the IRB any reports of adverse events that are serious, unlisted, and associated with 
the investigational technique and any new information that may adversely affect the safety 
of the subjects or the conduct of the study. 
Study personnel involved in conducting this study will be qualified by education, training, and 
experience to perform their task. 
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Informed Consent 
Before a subject’s participation in the study, it is the Investigator’s responsibility to obtain 
freely given consent, in writing, from the parents or patient’s legally acceptable representative 
after adequate explanation of the aims, methods, anticipated benefits, and potential hazards 
of the study.  
The ICF will be obtained by PI during the preoperative evaluation.  
Consent must represent the minor's presumed will and may be revoked at any time. 
Patients will be informed about the trial to the extent compatible with their understanding 
and, if capable, patients should sign and personally date informed consent form. 
In addition, the explicit wish of a minor who is capable of forming an opinion and assessing 
this information to refuse participation or to be withdrawn from this clinical trial at any time 
will be considered by the investigators. 
 
Subject Confidentiality 
The Investigators and the Sponsor will preserve the confidentiality of all subjects taking part 
in the study, in accordance with GCP and local regulations. The Investigator must ensure that 
the subject’s anonymity is maintained. On the CRFs or other documents submitted to the 
Sponsor, subjects should be identified by a unique subject identifier as designated by the 
Sponsor. Sponsor personnel whose responsibilities require access to personal data should 
agree to keep the identity of study subjects confidential. 
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Discussion 
 
Protective Lung Ventilation Strategy, a strategy characterized by low Vts, high PEEP and the 
use of RMs, has been developed in ICU context as a ventilation strategy for ARDS adult 
patients and is now the current standard of care for MV in critically ill patients. Over the last 
years, the use of such ventilatory strategies in the perioperative period has mobilized 
interesting research studies, especially for adult population4, with positive results in 
preventing Post-operative Pulmonary Complications31,32. 
  
Previous studies 
In regard to RM in Adults Laparoscopy, in several studies it has been demonstrated that RM is 
effective in improving lung compliance and lung mechanics16–18,29. Nevertheless, children 
should not be considered as small adults and the generalization of such conclusions could not 
be sufficiently justified. 
 
In the context of Pediatric Intensive Care Units (PICUs), studies have been developed to 
estimate the benefits of RMs.   
 
In an observational prospective study, Duff et al. performed Sustained Inflation (SI) (30–40 cm 
H2O for 15–20 seconds) on ventilated patients in the PICU with hypoxemia. During the RM  
there was no blood pressure, heart rate or oxygen saturation changes, and a significant FiO2 
reduction was seen in the 6 hours following the procedure. They concluded that RMs (as SI) 
are safe in ventilated PICU patients and are associated with a significant reduction in oxygen 
requirements for the 6 h after the RM20. 
 
In ARDS children, Gaudencio et al. using progressive PEEP levels and 15 cm H2O controlled 
pressure until obtaining less than 5% collapse in the tomography, found improved PaO2/FiO2 
ratio21. 
 
However, clinical trials in children in ICU have still shown controversial findings21. In addition 
to the observed beneficial effects, RM in critically ill pediatric patients may also have untoward 
effects such as inflammatory cytokines release21 
 
Two studies performed in children with not known lung disease undergoing general 
anesthesia for either computed tomography or magnetic resonance imaging showed a 
decrease in atelectasis as measured by thoracic computed tomography or magnetic 
resonance imaging with intermittent RMs22,33,34 
 
Finally, in the context of perioperative period, Marcus et al. demonstrated that a RM improves 
Comdyn in anaesthetized young children; laparoscopic surgery, however, was included in 
exclusion criteria 35. Scohy et al. concluded that a RM with relative high PEEP significantly 
improves compliance, oxygenation, (PaCO2 – PETCO2) difference and EELV in pediatric patients 
undergoing cardiac surgery for congenital heart disease, with the RM being performed post-
operatively, in PICU. 
 
To our knowledge, this study will be the first where RM will be performed intra-operatively in 
pediatric patients under laparoscopy. 
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Limitations of the study 
This study is aimed to  demonstrate a restoration in Comdyn and gas exchange by the RM. It 
will not be powered to describe overall pulmonary outcomes, such as postoperative 
atelectasis or lung infection. 
 
Lung mechanics include a variety of properties approaching lung function in a spherical way; 
this study, however, is limited to Comdyn – as an easily accessible parameter in everyday clinical 
practice.  
 
Our study population will be healthy and heterogeneous in terms of age and therefore size. 
Although Comdyn will be adjusted by weight, Comdyn may be affected by other factors related 
to age, such as compliance of the chest wall and resistance of the airways. In addition, both 
the ventilator used and the measurement technique used to obtain Comdyn could also affect 
our results. 
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Appendix 1 - Permuted Blocks Randomization 
30 subjects randomized into 5 blocks 
 
 
 
 
 
 
Appendix 2 - Sample Size Estimation 
Using Power Analysis for Comparison of Means for Two Independent Groups [Clinical Trial 
Methodology. Lecture 2016, Elias Zintzaras] 
The formula to calculate the sample size is  
 
 
where N is the total sample size (the sum of the sizes of both comparison groups), σ is the 
assumed SD of each group (assumed to be equal for both groups), the Ζcrit value is that given 
for the desired significance criterion, the Zpwr value is that given for the desired statistical 
power, and D is the minimum expected difference between the two means36 
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Appendix 3 - Demographic intra- & post-operative patient's data 
 
Patient ID  
Age (years)  
ASA (n)  
Weight (grams)  
Height (m)  
BMI (kg/m2)  
Sex (male / female)  
Type of Surgery  
Duration of Anesthesia (min)  
Duration of Pneumoperitoneum (min)  
IAP (mmHg)  
Crystalloids (ml)  
Blood (units)  
Need for Vasoconstrictor drugs (n)  
Length of Hospital stay (days)  
Pulmonary Complications (n)  
 
 
 
 
Appendix 4 - Mechanical Ventilation patient's data 
 
Patient ID: Time Point 
T1 T2 T2c T3 T3c T4 T4c T5 
Comdyn (ml/cm H2O)         
Comdyn-wc (ml/cm H2O*kg)         
PIP (cm H2O)         
Vt (ml)         
RR (breaths/min)         
MinV (ml)         
EtCO2 (mmHg)         
         
 
 
 
Appendix 5 - Hemodynamic patient's data 
 
Patient ID: Time Point 
T1 T2 T2c T3 T3c T4 T4c T5 T6 
SBP          
DBP          
MAP          
HR          
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Appendix 6 - Patient's Blood Gas Data 
 
Patient ID: Time Point 
T1 T2 T2c T3 T3c T4 T4c T5 T6 
pH  - - - - -    
PO2  - - - - -    
PCO2  - - - - -    
PO2 / FiO2  - - - - -    
SpO2          
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